Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001549595-24-000148

Chief Financial Officer sold 2,368 shares at $24.31 ($57,554)

  • Chief Financial Officer acquired 8,636 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

van Houte Hans · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-10-30 Exercise or conversion : show line 1 in the form +2,886 33,888 D
2024-10-30 Exercise or conversion : show line 2 in the form +2,000 35,888 D
2024-10-30 Exercise or conversion : show line 3 in the form +3,750 39,638 D
2024-10-30 Sale : show line 4 in the form −2,368 $24.31 $57,554 37,270 D
Open-market sales · 2,368 sh · avg $24.31 · $57,554

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-10-30 Exercise or conversion : show line 5 in the form Restricted Stock Units −2,886 14,431 D
2024-10-30 Exercise or conversion : show line 6 in the form Restricted Stock Units −2,000 12,000 D
2024-10-30 Exercise or conversion : show line 7 in the form Restricted Stock Units −3,750 37,500 D
Loading xslF345X05/wk-form4_1730334620.xml…